Financial Snapshot

Revenue
$3.090M
TTM
Gross Margin
Net Earnings
-$24.32M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
416.74%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
$2.608M
Q3 2024
Book Value
$8.504M
Q3 2024
Cash
Q3 2024
P/E
-0.8729
Nov 29, 2024 EST
Free Cash Flow
-$21.56M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Revenue $0.00 $81.53K $385.5K $1.824M $1.176M $963.2K $1.075M $828.9K $428.1K $883.0K $2.418M $2.657M $4.900M $5.190M $3.670M $2.910M $240.0K $850.0K $670.0K $720.0K $0.00 $20.00K $2.620M $860.0K $2.280M $5.370M $2.730M $90.00K $180.0K $9.600M
YoY Change -100.0% -78.85% -78.86% 55.09% 22.08% -10.42% 29.72% 93.64% -51.52% -63.48% -9.02% -45.77% -5.59% 41.42% 26.12% 1112.5% -71.76% 26.87% -6.94% -100.0% -99.24% 204.65% -62.28% -57.54% 96.7% 2933.33% -50.0% -98.13%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Revenue $0.00 $81.53K $385.5K $1.824M $1.176M $963.2K $1.075M $828.9K $428.1K $883.0K $2.418M $2.657M $4.900M $5.190M $3.670M $2.910M $240.0K $850.0K $670.0K $720.0K $0.00 $20.00K $2.620M $860.0K $2.280M $5.370M $2.730M $90.00K $180.0K $9.600M
Cost Of Revenue $0.00 $20.00K $2.750M $2.880M $4.830M $5.760M $4.350M $280.0K $90.00K $47.87M
Gross Profit $0.00 $10.00K -$130.0K -$2.020M -$2.550M -$390.0K -$1.620M -$190.0K $90.00K -$38.26M
Gross Profit Margin 50.0% -4.96% -234.88% -111.84% -7.26% -59.34% -211.11% 50.0% -398.54%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Selling, General & Admin $6.022M $4.987M $3.577M $2.200M $1.640M $1.650M $1.230M $2.130M $1.430M $1.810M $1.790M $1.750M $2.970M $3.160M $2.910M $2.970M $2.780M $840.0K $660.0K $530.0K $680.0K $2.410M $4.740M $3.630M $3.410M $3.270M $1.490M $1.010M $680.0K $4.950M
YoY Change 20.77% 39.4% 62.6% 34.15% -0.61% 34.15% -42.25% 48.95% -20.99% 1.12% 2.29% -41.08% -6.01% 8.59% -2.02% 6.83% 230.95% 27.27% 24.53% -22.06% -71.78% -49.16% 30.58% 6.45% 4.28% 119.46% 47.52% 48.53% -86.26%
% of Gross Profit 24100.0% 755.56%
Research & Development $20.72M $9.123M $15.55M $2.444M $1.911M $1.879M $2.017M $1.971M $1.693M $1.813M $2.915M $3.044M $4.280M $4.790M $4.070M $3.740M $1.760M $670.0K $1.640M $2.570M $2.430M $1.470M $510.0K $1.580M $830.0K $80.00K $20.00K $940.0K
YoY Change 127.11% -41.34% 536.3% 27.93% 1.71% -6.88% 2.36% 16.41% -6.61% -37.8% -4.23% -28.89% -10.65% 17.69% 8.82% 112.5% 162.69% -59.15% -36.19% 65.31% 188.24% -67.72% 90.36% 937.5% 300.0% -97.87%
% of Gross Profit 22.22%
Depreciation & Amortization $74.17K $56.28K $38.52K $19.66K $8.350K $19.80K $28.03K $28.78K $28.94K $69.04K $78.86K $93.64K $110.0K $120.0K $90.00K $60.00K $50.00K $50.00K $40.00K $20.00K $0.00 $30.00K $1.630M $830.0K $1.100M $320.0K $90.00K $30.00K $40.00K $710.0K
YoY Change 31.78% 46.11% 95.98% 135.4% -57.83% -29.35% -2.62% -0.54% -58.09% -12.46% -15.78% -14.87% -8.33% 33.33% 50.0% 20.0% 0.0% 25.0% 100.0% -100.0% -98.16% 96.39% -24.55% 243.75% 255.56% 200.0% -25.0% -94.37%
% of Gross Profit 300.0% 44.44%
Operating Expenses $26.74M $14.11M $19.13M $4.640M $3.548M $3.526M $3.250M $4.102M $3.123M $3.621M $4.707M $4.796M $7.250M $7.960M $6.980M $6.710M $4.540M $1.510M $2.300M $3.090M $680.0K $2.410M $8.270M $5.510M $3.920M $4.850M $2.310M $1.080M $710.0K $5.880M
YoY Change 89.53% -26.25% 312.27% 30.78% 0.64% 8.5% -20.78% 31.36% -13.75% -23.08% -1.86% -33.84% -8.92% 14.04% 4.02% 47.8% 200.66% -34.35% -25.57% 354.41% -71.78% -70.86% 50.09% 40.56% -19.18% 109.96% 113.89% 52.11% -87.93%
Operating Profit -$26.74M -$14.03M -$18.75M -$2.817M -$2.372M -$2.563M -$2.174M -$3.273M -$2.695M -$2.738M -$2.289M -$2.139M -$680.0K -$2.400M -$8.400M -$7.530M -$6.470M -$5.240M -$3.930M -$1.270M -$620.0K -$44.14M
YoY Change 90.63% -25.16% 565.5% 18.73% -7.42% 17.86% -33.57% 21.47% -1.57% 19.57% 7.04% -71.67% -71.43% 11.55% 16.38% 23.47% 33.33% 209.45% 104.84% -98.6%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Interest Expense $776.2K $0.00 $1.286K $143.5K $4.495K $2.590K $10.00K $0.00 $0.00 $0.00 $0.00 $20.00K $30.00K $70.00K $60.00K $70.00K $10.00K $30.00K -$60.00K $320.0K -$270.0K -$70.00K -$2.100M -$970.0K -$80.00K $0.00 $0.00 -$80.00K
YoY Change -100.0% -99.1% 3092.97% 73.55% -100.0% -33.33% -57.14% 16.67% -14.29% 600.0% -66.67% -150.0% -118.75% -218.52% 285.71% -96.67% 116.49% 1112.5% -100.0%
% of Operating Profit
Other Income/Expense, Net $7.439K $175.5K -$141.3K $1.864K $2.623K $4.286K $1.666K $5.465K $4.063K $4.545K $3.820K
YoY Change -95.76% -224.25% -7677.95% -28.94% -38.8% 157.26% -69.52% 34.51% -10.61% 18.98%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Pretax Income -$25.97M -$14.02M -$18.57M -$2.960M -$2.370M -$2.560M -$2.170M -$3.270M -$2.690M -$2.730M -$2.280M -$2.140M -$2.350M -$2.750M -$3.280M -$3.730M -$4.240M -$580.0K -$1.610M -$2.350M -$740.0K -$2.090M -$13.25M -$7.520M -$9.310M -$6.130M -$3.990M -$1.400M -$790.0K -$49.17M
YoY Change 85.2% -24.5% 527.38% 24.89% -7.42% 17.97% -33.64% 21.56% -1.47% 19.74% 6.54% -8.94% -14.55% -16.16% -12.06% -12.03% 631.03% -63.98% -31.49% 217.57% -64.59% -84.23% 76.2% -19.23% 51.88% 53.63% 185.0% 77.22% -98.39%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$25.97M -$14.02M -$18.57M -$2.958M -$2.371M -$2.560M -$2.170M -$3.272M -$2.689M -$2.734M -$2.285M -$2.135M -$2.350M -$2.750M -$3.280M -$3.730M -$4.240M -$580.0K -$1.610M -$2.350M -$3.080M -$5.070M -$13.25M -$7.520M -$9.310M -$6.130M -$3.990M $36.67M -$790.0K -$49.17M
YoY Change 85.2% -24.5% 527.79% 24.78% -7.4% 17.97% -33.67% 21.66% -1.62% 19.63% 7.02% -9.14% -14.55% -16.16% -12.06% -12.03% 631.03% -63.98% -31.49% -23.7% -39.25% -61.74% 76.2% -19.23% 51.88% 53.63% -110.88% -4741.77% -98.39%
Net Earnings / Revenue -17198.35% -4817.19% -162.21% -201.6% -265.79% -201.82% -394.7% -628.22% -309.59% -94.51% -80.35% -47.96% -52.99% -89.37% -128.18% -1766.67% -68.24% -240.3% -326.39% -25350.0% -505.73% -874.42% -408.33% -114.15% -146.15% 40744.44% -438.89% -512.19%
Basic Earnings Per Share -$14.29 -$0.83 -$3.04
Diluted Earnings Per Share -$14.29 -$0.83 -$3.044M -$2.145M -$785.0M -$313.0B -$632.6B -$1576B -$1683B -$2052B -$2154B -$2331B -$2983B -$3511B -$4324B -$5037B -$5939B -$1408B -$5154B -$8085B -$9082B -$31050B -$209900B -$128000B -$201400B -$164400B -$129800B -$57970B -$55100B -$3412000B

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Cash & Short-Term Investments $6.453M $27.61M $11.42M $9.880M $280.0K $260.0K $310.0K $450.0K $1.060M $1.100M $2.510M $1.040M $1.170M $1.080M $3.520M $2.190M $1.990M $2.090M $1.270M $10.00K $0.00 $730.0K $2.680M $30.00K $60.00K $3.620M $390.0K $90.00K
YoY Change -76.63% 141.71% 15.63% 3428.57% 7.69% -16.13% -31.11% -57.55% -3.64% -56.18% 141.35% -11.11% 8.33% -69.32% 60.73% 10.05% -4.78% 64.57% 12600.0% -72.76% 8833.33% -50.0% -98.34% 828.21% 333.33%
Cash & Equivalents $6.453M $27.61M $11.42M $9.880M $280.0K $260.0K $310.0K $450.0K $1.060M $1.100M $2.510M $1.040M $1.170M $1.080M $3.520M $2.190M $1.990M $2.090M $1.270M
Short-Term Investments
Other Short-Term Assets $1.433M $1.326M $156.2K $170.0K $100.0K $240.0K $80.00K $60.00K $60.00K $40.00K $40.00K $40.00K $70.00K $50.00K $40.00K $300.0K $950.0K $40.00K $160.0K $10.00K $170.0K $40.00K $20.00K $40.00K $50.00K $40.00K $240.0K $0.00
YoY Change 8.08% 748.69% -8.09% 70.0% -58.33% 200.0% 33.33% 0.0% 50.0% 0.0% 0.0% -42.86% 40.0% 25.0% -86.67% -68.42% 2275.0% -75.0% 1500.0% -94.12% 100.0% -50.0% -20.0% 25.0% -83.33%
Inventory $520.0K $510.0K $1.520M $2.950M $1.530M $2.650M $90.00K
Prepaid Expenses
Receivables $0.00 $49.01K $180.0K $70.00K $120.0K $60.00K $30.00K $120.0K $80.00K $140.0K $270.0K $180.0K $470.0K $320.0K $310.0K $90.00K $0.00 $0.00 $0.00 $70.00K $320.0K $130.0K $690.0K $460.0K $0.00 $170.0K
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $0.00 $50.00K $20.00K $0.00 $0.00
Total Short-Term Assets $7.886M $28.94M $11.63M $10.24M $450.0K $620.0K $450.0K $540.0K $1.240M $1.230M $2.700M $1.340M $1.420M $1.600M $3.880M $2.800M $3.030M $2.130M $1.440M $20.00K $170.0K $1.350M $3.550M $1.720M $3.790M $5.670M $3.290M $360.0K
YoY Change -72.75% 148.85% 13.57% 2175.56% -27.42% 37.78% -16.67% -56.45% 0.81% -54.44% 101.49% -5.63% -11.25% -58.76% 38.57% -7.59% 42.25% 47.92% 7100.0% -88.24% -61.97% 106.4% -54.62% -33.16% 72.34% 813.89%
Property, Plant & Equipment $209.7K $234.9K $156.9K $150.0K $10.00K $10.00K $30.00K $50.00K $80.00K $100.0K $120.0K $100.0K $180.0K $250.0K $340.0K $140.0K $80.00K $110.0K $60.00K $1.830M $1.480M $1.370M $1.670M $740.0K $120.0K $70.00K
YoY Change -10.74% 49.68% 4.63% 1400.0% 0.0% -66.67% -40.0% -37.5% -20.0% -16.67% 20.0% -44.44% -28.0% -26.47% 142.86% 75.0% -27.27% 83.33% 23.65% 8.03% -17.96% 125.68% 516.67% 71.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $290.0K $290.0K $300.0K $0.00
YoY Change -100.0% 0.0% -3.33%
Other Assets $1.188M $2.174M $11.01K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $10.00K $440.0K $0.00 $0.00 $0.00 $0.00 $0.00 $440.0K $750.0K $0.00 $190.0K $0.00
YoY Change -45.37% 19648.32% 10.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -97.73% -41.33% -100.0%
Total Long-Term Assets $1.397M $2.409M $167.9K $150.0K $20.00K $20.00K $40.00K $70.00K $90.00K $100.0K $140.0K $140.0K $230.0K $760.0K $440.0K $260.0K $220.0K $270.0K $250.0K $0.00 $0.00 $2.570M $7.610M $1.650M $2.930M $1.600M $110.0K $70.00K
YoY Change -41.99% 1334.56% 11.96% 650.0% 0.0% -50.0% -42.86% -22.22% -10.0% -28.57% 0.0% -39.13% -69.74% 72.73% 69.23% 18.18% -18.52% 8.0% -66.23% 361.21% -43.69% 83.13% 1354.55% 57.14%
Total Assets $9.283M $31.35M $11.80M $10.39M $470.0K $640.0K $490.0K $610.0K $1.330M $1.330M $2.840M $1.480M $1.650M $2.360M $4.320M $3.060M $3.250M $2.400M $1.690M $20.00K $170.0K $3.920M $11.16M $3.370M $6.720M $7.270M $3.400M $430.0K
YoY Change
Accounts Payable $2.803M $1.748M $2.058M $270.0K $150.0K $130.0K $80.00K $80.00K $100.0K $60.00K $160.0K $160.0K $140.0K $100.0K $410.0K $180.0K $390.0K $80.00K $140.0K $70.00K $130.0K $480.0K $290.0K $1.900M $2.100M $790.0K $200.0K $180.0K
YoY Change 60.38% -15.06% 662.05% 80.0% 15.38% 62.5% 0.0% -20.0% 66.67% -62.5% 0.0% 14.29% 40.0% -75.61% 127.78% -53.85% 387.5% -42.86% 100.0% -46.15% 65.52% -84.74% -9.52% 165.82% 295.0% 11.11%
Accrued Expenses $716.9K $3.000M $3.378M $360.0K $1.850M $1.240M $730.0K $290.0K $0.00 $50.00K $100.0K $30.00K $130.0K $240.0K $0.00 $50.00K $110.0K $120.0K $320.0K $370.0K $100.0K $80.00K $30.00K $220.0K $290.0K $60.00K $70.00K
YoY Change -76.1% -11.18% 838.29% -80.54% 49.19% 69.86% 151.72% -100.0% -50.0% 233.33% -76.92% -45.83% -100.0% -54.55% -8.33% -62.5% -13.51% 25.0% 166.67% -86.36% -24.14% 383.33% -14.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $960.0K $1.190M $0.00 $0.00 $290.0K $250.0K $90.00K $0.00 $760.0K
YoY Change -100.0% -19.33% -100.0% 16.0% 177.78% -100.0%
Long-Term Debt Due $0.00 $180.0K $10.00K $260.0K $960.0K $1.110M $80.00K $110.0K $130.0K $970.0K $80.00K $0.00 $0.00
YoY Change -100.0% 1700.0% -96.15% -13.51% -27.27% -15.38% -86.6% 1112.5%
Total Short-Term Liabilities $3.520M $4.748M $5.435M $810.0K $2.020M $1.620M $810.0K $370.0K $130.0K $190.0K $310.0K $330.0K $940.0K $520.0K $570.0K $350.0K $600.0K $190.0K $1.170M $2.560M $3.990M $670.0K $540.0K $2.640M $3.530M $1.250M $270.0K $51.34M
YoY Change -25.86% -12.65% 571.03% -59.9% 24.69% 100.0% 118.92% 184.62% -31.58% -38.71% -6.06% -64.89% 80.77% -8.77% 62.86% -41.67% 215.79% -83.76% -54.3% -35.84% 24.07% -79.55% -25.21% 182.4% 362.96% -99.47%
Long-Term Debt $0.00 $0.00 $0.00 $10.00K $30.00K $40.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.020M $2.410M $0.00 $1.200M $100.0K $190.0K $300.0K $350.0K $40.00K $0.00
YoY Change -100.0% -66.67% -25.0% -100.0% -57.68% 1100.0% -47.37% -36.67% -14.29% 775.0%
Other Long-Term Liabilities $0.00 $2.000M
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $2.000M $10.00K $30.00K $40.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.020M $2.410M $0.00 $1.200M $100.0K $190.0K $300.0K $350.0K $40.00K $0.00
YoY Change -100.0% 19900.0% -66.67% -25.0% -100.0% -57.68% 1100.0% -47.37% -36.67% -14.29% 775.0%
Total Liabilities $3.520M $4.748M $7.435M $830.0K $2.040M $1.660M $810.0K $370.0K $130.0K $190.0K $310.0K $330.0K $940.0K $520.0K $570.0K $350.0K $600.0K $190.0K $2.190M $4.970M $3.990M $1.870M $640.0K $2.820M $3.830M $1.590M $310.0K $51.34M
YoY Change -25.86% -36.14% 795.83% -59.31% 22.89% 104.94% 118.92% 184.62% -31.58% -38.71% -6.06% -64.89% 80.77% -8.77% 62.86% -41.67% 215.79% -91.32% -55.94% 24.56% 192.19% -77.3% -26.37% 140.88% 412.9% -99.4%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994
Basic Shares Outstanding 1.817M 16.97M 6.100M
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $21.231 Million

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is headquartered in Smyrna, Georgia and currently employs 17 full-time employees. Its product pipeline includes ongoing human clinical trials for a Covid-19 vaccine and a gene-directed therapy against advanced head and neck cancers. Its additional research and development programs include preventive vaccines against Mpox and smallpox, hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan and Marburg), Zika virus and malaria, as well as immunotherapies for multiple solid tumors. The Company’s portfolio of wholly owned, co-owned, and in-licensed intellectual property, stands at over 155 granted or pending patent applications spread over 24 patent families. Its product candidate includes GEO-CM04S1, GEO-CM02, Gedeptin, MVA-VLP-MUC1, GEO-ZM02 and others. Its lead infectious disease candidate is GEO-CM04S1, a COVID-19 vaccine targeting high-risk immunocompromised patient populations.

Industry: Pharmaceutical Preparations Peers: Elevation Oncology, Inc. 180 Life Sciences Corp. Aptinyx Inc. eFFECTOR Therapeutics, Inc. ORAGENICS INC Regulus Therapeutics Inc. Tonix Pharmaceuticals Holding Corp. TREVENA INC